Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
790.00    -4.00 (-0.50%)
Bid:
784.00
Ask:
808.00
Spread: 24.00 (3.061%)
Market Cap: £364.16m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Director/PDMR Shareholding

28 Jun 2019 11:30

RNS Number : 8425D
Porvair PLC
28 June 2019
 

 

Porvair plc ("Porvair" or the "Company")

Director's Shareholding

The Company was notified on 27 June 2019 of the following exercises of Long Term Share Plan Share options ("LTSP") over ordinary shares of 2 pence each in the Company ("Ordinary Shares").

Director

Scheme

Year of grant

Exercise price

Options exercised

Ben Stocks

LTSP

2016

2.0p

96,700

Chris Tyler

LTSP

2016

2.0p

67,900

On the same day, the Company was notified that Ben Stocks, Group CEO, and Chris Tyler, Group Finance Director, had sold the following Ordinary Shares in order to meet the cost of exercise, the personal taxation liabilities arising on the options and certain other financial commitments.

Director

Transaction

Price

Number

Ben Stocks

Sale

£5.82

76,700

Chris Tyler

Sale

£5.82

52,900

The Company was also notified on 27 June 2019 of the following purchase on 7 June 2019 by Ben Stocks of Ordinary Shares pursuant to the Group's dividend reinvestment plan ("DRIP").

Director

Transaction

Price

Number

Ben Stocks

DRIP purchase

£5.68

3,513

Following these dealings, Ben Stocks' holding in the Company has increased by 23,513 Ordinary Shares to 762,933 Ordinary Shares, representing approximately 1.7 per cent. of the Company's issued share capital. Chris Tyler's holding in the Company has increased by 15,000 Ordinary Shares to 494,311 Ordinary Shares, representing approximately 1.1 per cent. of the Company's issued share capital.

As at today's date, the total number of voting rights in the Company is 45,843,599. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information, please contact:

Porvair plc

01553 765 500

Chris Tyler, Group Finance Director

Notes to Editors

Porvair is a group of specialist filtration and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

 

The information below (set out in accordance with the requirements of EU Market Abuse Regulation) provides further detail:

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Christopher Tyler

2.

Reason for the notification

a.

Position/status

CFO

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Porvair plc

b.

LEI

213800ECKHS8LAQO3C45

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type

of instrument

Identification code

Ordinary shares of 2p

 

 

GB0006963689

b.

Nature of the transaction

 

1) Exercise of LTSP share options

 

2) Sale of ordinary shares

 

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

1)

£0.02

67,900

2)

£5.82

52,900

d.

Aggregated information

· Aggregated volume

· Price

 

 

As above

e.

Date of the transaction

27 June 2019

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Ben Stocks

2.

Reason for the notification

a.

Position/status

CEO

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Porvair plc

b.

LEI

213800ECKHS8LAQO3C45

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type

of instrument

Identification code

Ordinary shares of 2p

 

 

GB0006963689

b.

Nature of the transaction

 

1) Exercise of LTSP share options

 

2) Sale of ordinary shares

 

3) Purchase of shares through the dividend reinvestment plan

 

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

1)

£0.02

96,700

2)

£5.82

76,700

3)

£5.68

3,513

d.

Aggregated information

· Aggregated volume

· Price

 

 

As above

e.

Date of the transaction

27 June 2019

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHZMGZVGRKGLZM
Date   Source Headline
11th Nov 20201:17 pmRNSHolding(s) in Company
9th Nov 20207:00 amRNSDirectorate Change
23rd Oct 20204:40 pmRNSSecond Price Monitoring Extn
23rd Oct 20204:35 pmRNSPrice Monitoring Extension
7th Oct 20204:35 pmRNSPrice Monitoring Extension
28th Sep 20204:41 pmRNSSecond Price Monitoring Extn
28th Sep 20204:35 pmRNSPrice Monitoring Extension
22nd Sep 20207:00 amRNSNine months trading update
18th Sep 20203:58 pmRNSChange of auditor
2nd Sep 20202:09 pmRNSHolding(s) in Company
19th Aug 20204:03 pmRNSDirector/PDMR Shareholding
10th Aug 20204:40 pmRNSSecond Price Monitoring Extn
10th Aug 20204:36 pmRNSPrice Monitoring Extension
31st Jul 20207:00 amRNSTotal Voting Rights
3rd Jul 20204:41 pmRNSSecond Price Monitoring Extn
3rd Jul 20204:36 pmRNSPrice Monitoring Extension
29th Jun 20207:00 amRNSHalf Year Results 2020
25th Jun 20204:52 pmRNSDirector/PDMR Shareholding
2nd Jun 20204:36 pmRNSPrice Monitoring Extension
20th May 20204:36 pmRNSPrice Monitoring Extension
19th May 20204:36 pmRNSPrice Monitoring Extension
23rd Apr 20209:27 amRNSPublication of Articles of Association
21st Apr 20201:59 pmRNSAGM resolutions and Board changes
8th Apr 20204:03 pmRNSBlock listing six monthly return
8th Apr 20207:00 amRNSTrading Update and Covid-19 Statement
30th Mar 20204:36 pmRNSPrice Monitoring Extension
30th Mar 202012:08 pmRNSSecond Price Monitoring Extn
30th Mar 202012:02 pmRNSPrice Monitoring Extension
26th Mar 202012:07 pmRNSSecond Price Monitoring Extn
26th Mar 202012:02 pmRNSPrice Monitoring Extension
26th Mar 20207:00 amRNSAnnual General Meeting 2020 – Change of Venue
23rd Mar 20204:43 pmRNSSecond Price Monitoring Extn
23rd Mar 20204:38 pmRNSPrice Monitoring Extension
20th Mar 20204:43 pmRNSSecond Price Monitoring Extn
20th Mar 20204:37 pmRNSPrice Monitoring Extension
19th Mar 20204:43 pmRNSSecond Price Monitoring Extn
19th Mar 20204:39 pmRNSPrice Monitoring Extension
18th Mar 202012:08 pmRNSSecond Price Monitoring Extn
18th Mar 202012:03 pmRNSPrice Monitoring Extension
17th Mar 20204:41 pmRNSSecond Price Monitoring Extn
17th Mar 20204:38 pmRNSPrice Monitoring Extension
13th Mar 20204:42 pmRNSSecond Price Monitoring Extn
13th Mar 20204:36 pmRNSPrice Monitoring Extension
6th Mar 202010:20 amRNSHolding(s) in Company
18th Feb 202012:07 pmRNSSecond Price Monitoring Extn
18th Feb 202012:02 pmRNSPrice Monitoring Extension
18th Feb 20207:00 amRNSDirector/PDMR Shareholding
11th Feb 20203:15 pmRNSPDMR Shareholding Grant of Options
3rd Feb 20207:00 amRNSPreliminary Results and Board Changes
18th Dec 20195:39 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.